Sharing is caring!

One of the many challenges the pharmaceutical industry faces amidst COVID-19 is the possibility of drug shortages, especially as countries around the world rely on China for much of their active pharmaceutical ingredients (APIs).

However, Sanofi said that they are not worried over supply shortages during this time of crisis, they said that they are working constantly on ensuring the continuity of its supply chain through close collaboration with its suppliers throughout the world. 

According to its official statement against COVID-19, Sanofi has safeguarded itself against shortages from major suppliers in China, India, and other Asian countries because it relies on ingredients from a variety of global sources, not just one country or source.

The statement added that its global network of manufacturing plants is operational and the aforementioned diversity of global sourcing. 

(Source: Policy Med, 2020)